Virpax Pharmaceuticals In...
(VRPX)
undefined
undefined%
At close: undefined
0.36
-11.00%
Pre-market Dec 16, 2024, 07:52 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Net Income | -15.19M | -21.65M | -12.06M | -4.34M | -3.31M | -2.64M |
Depreciation & Amortization | - | - | - | - | - | - |
Stock-Based Compensation | 544.77K | 745.03K | 974.23K | 1.47M | 678.15K | 384.95K |
Other Working Capital | 4.19M | 4.05M | -2.71M | -13.09K | 7.95K | -13.13K |
Other Non-Cash Items | 599.43K | 745.03K | -61.82K | 153.22K | 564.64K | 14.98K |
Deferred Income Tax | - | - | - | - | - | - |
Change in Working Capital | 4.19M | 3.06M | -3.40M | 1.33M | 931.89K | 441.37K |
Operating Cash Flow | -9.85M | -17.85M | -14.54M | -1.38M | -1.13M | -1.80M |
Capital Expenditures | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - | - |
Other Investing Acitivies | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Debt Repayment | - | - | -1.50M | 72.10K | 500.00K | 554.77K |
Common Stock Repurchased | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - |
Other Financial Acitivies | - | - | -5.19M | -50.88K | 625.00K | - |
Financial Cash Flow | - | - | 51.33M | 1.40M | 1.13M | 1.67M |
Net Cash Flow | -9.85M | -17.85M | 36.79M | 13.26K | -6.83K | -124.87K |
Free Cash Flow | -9.85M | -17.85M | -14.54M | -1.38M | -1.13M | -1.80M |